Streetbeat News

Revenues

APLM

Apollomics Inc. (NASDAQ:APLM) announced a private placement financing deal expected to generate approximately $6 million in gross proceeds. The company will sell around 19.2 million Class A ordinary shares at $0.30 each to both new and existing investors. The financing is set to close on May 8, 2024, and the funds will be used to support Apollomics' oncology drug development programs and for general corporate purposes.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 9:28 pm

SEER

Seer, Inc. projects its FY24 revenue to be between $16M and $18M, which falls below the analyst estimate of $18.9M.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 9:27 pm

COOK

Traeger, Inc. projects its FY24 revenue to be between $580M-$605M, compared to the estimated $591.845M by analysts.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 9:27 pm

SUPN

Supernus Pharmaceuticals has reaffirmed its fiscal year 2024 revenue forecast to be in the range of $580 million to $620 million, which is in line with the analyst estimate of $601.461 million.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 9:25 pm

MRMD

MariMed (OTC:MRMD) reported Q1 sales of $37.933M, surpassing the analyst consensus estimate of $36.950M by 2.66% and marking a 10.33% increase from the previous year's sales of $34.380M.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 9:25 pm

GTBIF

Green Thumb Industries (OTCQX:GTBIF) reported an 11% increase in Q1 2024 revenue to $276 million, with a GAAP net income of $31 million, marking a 240% year-over-year increase. Adjusted EBITDA rose to $91 million, and cash flow from operations increased by 12% to $84 million. The growth is attributed to expanded retail operations and consumer packaged goods sales, including 15 additional RISE Dispensaries and new adult-use sales in Maryland. The company also repurchased 1,067,000 shares for $13.6 million.

Portfolio Pulse from Maureen Meehan

May 08, 2024 | 9:22 pm

PETQ

PetIQ anticipates Q2 net sales to be between $325M-$335M, slightly below the estimated $335.976M, but has raised its FY24 forecast from $1.130B-$1.180B to $1.135B-$1.185B, surpassing the estimated $1.149B. The company also expects Q2 adjusted EBITDA of $34.0M-$36.0M and FY24 adjusted EBITDA of $112.0M-$118.0M.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 9:20 pm

LSF

Laird Superfood projects its FY24 net sales to be between $38M and $42M, indicating a growth rate of 11-23%.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 9:19 pm

TASK

TaskUs projects Q2 revenue to be between $230M-$232M, surpassing the estimated $227.02M, and forecasts FY24 revenue to be in the range of $925M-$950M, closely aligning with the estimated $927.86M.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 9:18 pm

STKL

SunOpta (NASDAQ:STKL) reported Q1 2024 earnings of $0.02 per share, missing the consensus estimate of $0.03. However, their sales of $182.848M exceeded the estimate of $168.397M, marking a 17.99% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 9:16 pm